Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Pfizer
Eastern Cooperative Oncology Group
AstraZeneca
Arvinas Inc.
Alliance for Clinical Trials in Oncology
Pfizer
University of Nebraska
M.D. Anderson Cancer Center
Azienda Ospedaliera di Padova
Columbia University
Algemeen Ziekenhuis Maria Middelares